Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Purchase Of Investment : HK$0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Purchase Of Investment?

Shenzhen Neptunus Interlong Bio-Technique Co's purchase of investment for the three months ended in Dec. 2024 was HK$0.0 Mil. It means Shenzhen Neptunus Interlong Bio-Technique Co spent HK$0.0 Mil on purchasing investments. Shenzhen Neptunus Interlong Bio-Technique Co's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.0 Mil.

Compared with last quarter (HK$0.0 Mil in Jun. 2024 ), Shenzhen Neptunus Interlong Bio-Technique Co spent the same money on purchasing investments in Dec. 2024 (HK$0.0 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co Purchase Of Investment Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Purchase Of Investment Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

-324.81

-300.00

-112.11

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen Neptunus Interlong Bio-Technique Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Purchase Of Investment

Traded in Other Exchanges

N/A

Address

979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG

Website

https://www.interlong.com

Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines